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ABSTRACT
The ethical aspects of biobanks and forensic DNA
databases are often treated as separate issues. As a
reﬂection of this, public participation, or the involvement
of citizens in genetic databases, has been approached
differently in the ﬁelds of forensics and medicine. This
paper aims to cross the boundaries between medicine
and forensics by exploring the ﬂows between the ethical
issues presented in the two domains and the subsequent
conceptualisation of public trust and legitimisation. We
propose to introduce the concept of ‘solidarity’,
traditionally applied only to medical and research
biobanks, into a consideration of public engagement in
medicine and forensics. Inclusion of a solidarity-based
framework, in both medical biobanks and forensic DNA
databases, raises new questions that should be included
in the ethical debate, in relation to both health services/
medical research and activities associated with the
criminal justice system.
INTRODUCTION
Both medical biobanks and forensic DNA databases
have the potential to provide great social beneﬁts.
Whereas medical biobanks are seen as one of the
most promising instruments for ﬁghting disease and
improving public health, since they can extend our
understanding of illnesses and the development of
therapies and treatments for common multifactorial
diseases as well as determine why certain groups of
people have different reactions to pharmaceutical
drugs,1 2 forensic DNA databases are seen as tools
that can improve efforts to detect crime and iden-
tify suspects, which is, in turn, expected to reduce
crime and increase public safety and security.3–6
Medical biobanks involve collection, storage and
use of human tissue, genotypes and other biological
information derived from this tissue, and a range of
data on personal health histories collected from
populations of various sizes. Forensic DNA data-
bases involve collection, storage and use of DNA
proﬁles from nominated suspects, convicted offen-
ders, victims, volunteers and other persons of inter-
est to criminal investigation work, so that the
proﬁles can be compared with those obtained from
crime scene samples used in crime investigations
and law enforcement. In the EU there is consider-
able variation in the criteria for inclusion of pro-
ﬁles, periods of time, and conditions for their
retention and/or deletion among national forensic
DNA databases.3 5 6 Two main groups can be iden-
tiﬁed: countries with legislation classiﬁed as having
expansive effects (Austria, Denmark, Estonia,
Finland, Latvia, Lithuania, Scotland, Slovakia, and
England and Wales); countries with legislation clas-
siﬁed as having restrictive effects (Belgium, France,
Germany, Hungary, Ireland, Italy, Luxemburg, The
Netherlands, Poland, Portugal, Romania, Spain and
Sweden). In the group of countries in which legisla-
tion is considered to have restrictive effects, the
condition generally imposed for inclusion of pro-
ﬁles in databases is that an individual is suspected
or convicted of a crime that involves a potential or
effective prison sentence, or the fact that the indi-
vidual subjected to collection of a biological sample
has committed crimes that are considered serious.
In the expansive group, the inclusion criteria in
most countries allow that individuals suspected of
any crime can be submitted to sample collection
and, consequently, to the inclusion of their respect-
ive DNA proﬁles in the forensic database.6
In forensic DNA databases, the type of genetic
data stored is potentially only identifying informa-
tion. However, in some EU jurisdictions, biological
samples, together with personal information, are
retained for the same period of time as the DNA pro-
ﬁles, which means that, in this situation, the forensic
DNA databases are equivalent to biobanks.3–6 For
the sake of clariﬁcation, the concept of biobanks will
be used in this paper to refer to the medical ﬁeld
only, and forensic DNA databases to refer to genetic
databases used in the criminal justice system.
Although both biobanks and forensic DNA data-
bases have been the subject of considerable eco-
nomic, political and scientiﬁc investment and
potentially offer great beneﬁts to society, an intense
ethical debate has emerged concerning the risks
and harm that may be associated with their use.
The complex ethical issues regarding the creation
and governance of forensic DNA databases and bio-
banks have generally been addressed by experts,
policy makers, regulators and academic commenta-
tors as separate ﬁelds of debate and analysis. The
separate discussion of ethical problems is usually
justiﬁed on the basis that forensic DNA databases
are used in a completely different context from
other biomedical tools and serve other purposes.3
In many ways, the idea of maintaining this separ-
ation is based on the argument that the ethical
aspects of medical biobanks should be framed
around individual rights and choices, whereas the
debate on forensic DNA databases should be con-
textualised in terms of the underlying political and
social choices.4 7
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This paper critically questions the separation between the
ethics of biobanks and forensic DNA databases. Positioning the
analysis within the current ethical debate in the medical and
forensic arenas, it aims to cross the boundaries between them by
exploring the ﬂows between the ethical issues presented in the
two domains in the ﬁeld of public participation, public trust and
legitimisation and the subsequent application of the principle of
‘solidarity’ to medical biobanks and forensic DNA databases.
ETHICS, MEDICAL BIOBANKS AND FORENSIC DNA
DATABASES
In the ethical debate, discussion of medical genetic databases
has been framed largely in terms of the autonomy of research
participants (principally informed consent and conﬁdentiality)
and issues such as commercialisation, ownership and public con-
ﬁdence in the governance of research.8 9 The ethical challenges
of forensic DNA databases have usually been approached as
potential threats to a range of civil rights, such as the right to
privacy, liberty and moral and physical integrity, the dignity of
persons, and the presumption of innocence. At the heart of the
debate related to ethics in the forensic ﬁeld lies a discussion of
the principle of proportionality (ie, the fundamental importance
to human beings of respect for their individual rights and the
need, in appropriate circumstances, to restrict these rights,
either in the general interest or to protect the rights of
others).10 11
A growing number of commentators argue that there is a
need to explore in greater depth the continuities and discontinu-
ities between parallel developments and ethical issues in forensic
databases and medical biobanks.4 7 12–14 This paper offers a
contribution to this perspective by extending the traditional
ethical debate on public participation in genetic databases.
Various examples of the ethical issues raised by ‘trading’
between forensic and medical databases can be cited, in particu-
lar the fact that genetic information might be used for wider
purposes than those for which the databases were originally
created, and that privacy and informed consent may be appro-
priately questioned in both forensic and medical ﬁelds. These
aspects of the possible ﬂows between medical biobanks and
forensic DNA databases and their respective ethical dilemmas
will now be discussed, by focusing on two main aspects: the use
of genetic data for purposes beyond those that originated the
collection of samples; issues of privacy and informed consent.
Biological samples contained in criminal DNA databases can
also be used for various forms of scientiﬁc and medical research
(eg, research into genetic predisposition to violent behaviour),
however unclear the ethics might be. Moreover, inclusion of
participants’ data in genetic databases in which the collection
and processing of data may be associated with individual or
group characteristics, criminal behaviour or medical conditions
may be seen as a situation that restricts individual privacy and
leads to discrimination and stigmatisation.4 13–16 Although
speculative automated searches between forensic and medical
contexts are banned in all Western jurisdictions, some countries
(Denmark and Sweden) have used blood samples collected from
newborn babies, which are held in screening biobanks to test for
phenylketonuria and other diseases, for DNA tests to identify
suspected criminals. These practices raise important challenges
in relation to technical and ethical interoperability of medical
and forensic biobanks. In addition, commercial players, such as
biotech companies, have expressed support and enthusiasm for
the expansion of forensic DNA databases, which could poten-
tially create opportunities for the future misuse of samples held
in state and privately owned laboratories.17 18
Concerns relating to informed consent and privacy are more
often emphasised by those writing about medical databases.
However, privacy is also the focus of the ethical debate on
forensic DNA databases, especially with regard to the retention
of samples and proﬁles of individuals who are not subsequently
brought before the courts or in cases when the prosecution fails
to establish their guilt.4 5
Informed consent is not typically considered an issue in the
context of forensic processing. However, although many juris-
dictions in Europe have stipulated that consent is not required
when taking a sample from individuals who have committed a
crime or who are criminal suspects (eg, Austria, Denmark,
Estonia, Finland, Latvia, Lithuania, Scotland, Slovakia, The
Netherlands, England and Wales) since they are considered to
hold fewer rights given the broader rights of society, other coun-
tries (such as Cyprus, France, Germany, Luxembourg, Portugal,
the Republic of Ireland and Spain) have decided that informed
consent is needed for samples collected during criminal pro-
ceedings, even if coercive sampling is allowed. Although collect-
ing samples from convicted offenders tends to be consensual,
the same cannot be said of collection of biological material
from criminal suspects, as suspects are supposed to be treated as
innocent until proven guilty. The storing of samples from non-
convicted suspects is even more problematic, as clearly high-
lighted by the decision of the European Court of Human
Rights, which held, within the S and Marper v United Kingdom
[2008] ECHR 1581, that holding DNA samples of individuals
who have been arrested but are later acquitted or have the
charges against them dropped is a violation of the right to
privacy under the European Convention on Human Rights.
It is our view that practices related to informed consent in
forensic contexts should be an important area of inquiry, which
is still clearly under-addressed and requires further investiga-
tion.4 12 The following practices support the idea that the
ethical debate on the implications of obtaining informed
consent would beneﬁt from being examined across the medical
and forensic ﬁelds: the act of taking a DNA sample is always
expected to be performed in accordance with standard medical
guidelines; the right to information of data subjects on the fore-
seeable risks and uncertainties posed by DNA sample collection
and DNA proﬁling, specifying the content and possible and
inadmissible uses of the samples, as well as their storage time
and availability; and the protection of individuals with regard to
processing of personal data and free movement of such data,
indicating the procedures associated with the recovery of
samples and data, and the terms under which samples and data
can be accessed.
PUBLIC PARTICIPATION
Reﬂecting the separate discussion on the ethics of forensic DNA
databases and medical biobanks, public participation or the
involvement of citizens in genetic databases has been
approached differently in the two ﬁelds of forensics and medi-
cine. The question of public participation is a key issue in the
governance of genetic databases and has been framed in two dif-
ferent ways: as people providing research material for genetic
databases, and as people becoming co-decision-makers in these
projects.13 These two aspects of public participation are gener-
ally considered important to the involvement of citizens in
medical research projects. In the case of forensic genetic data-
bases, the debate on public participation has been restricted to
public involvement in governance and policy decisions—that is,
the perception of citizens as co-decision makers—and therefore
the assumption that public concerns about human rights and
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civil liberties should be identiﬁed and, in the light of this, the
acceptable conditions for establishing and governing a forensic
DNA database should be amended.6 14–17 19 20 This differenti-
ation between the concept of public participation in biobanks
and forensic DNA databases can essentially be explained by the
fact that the latter is associated with the compulsory collection
of proﬁles and samples from individuals who have been
arrested, accused and convicted of crimes, for policing purposes,
whereas biobank records are assumed to rely on voluntary
participation.4 7 12
In our view, completely separating the ethical issues regarding
the governance of genetic databases in medicine from the DNA
databases used in criminal investigation restricts the ways in
which public participation is designed and conceived, for three
main reasons. First, the dichotomy of voluntary and compulsory
participation fails to consider certain concrete situations which
do not fall clearly into one category or the other (eg, volunteers
or victims of crime who provide DNA samples for criminal
genetic databases, as well as disease registries and investigations
into public health emergencies when data have been collected
without the need for individual informed consent).7 13 15
Second, this contraposition between DNA samples collected by
compulsion (associated with criminal genetic databases) and the
voluntary provision of human biological material (linked to
medical databases) is based on an individualistic approach to
ethics which focuses mainly on the potential restriction of indi-
vidual civil rights, while failing to consider collective and polit-
ical concerns, such as institutional oversight, public trust, and
transparency in the governance of genetic databases. Third, the
emphasis on ‘free choice’ on the part of those contributing to
biobanks has been extensively criticised, and several commenta-
tors have shown that the concept of ‘voluntary participation’ is
ambiguous and unclear.1 4 7 17 18 20 In the forensic criminal
ﬁeld, refusal to be a volunteer might be the basis for being
added to the list of ‘suspects’.4 The so-called practice of ‘DNA
dragnets’ in criminal investigation consists of asking hundreds,
even thousands, of people for their blood or saliva, in the hope
of ﬁnding the one person whose DNA matches DNA left at a
crime scene. In addition, recent studies indicate that the auto-
matic association of ‘compulsory participation’ with criminal
genetic databases is also problematic: not only may convicted
offenders see the inclusion of their individual genetic proﬁle as
a means of protecting their individual rights and increasing their
chances of exoneration, but ordinary citizens may also be
willing to voluntarily donate a sample for proﬁling and inclu-
sion in a criminal DNA database because of the perceived bene-
ﬁts of protecting both society and individuals from crime.11 21
Thus, the ethical debate about public participation in medical
biobanks can be meaningfully applied to public participation in
forensic arenas. In the next section we explore how ﬂow
between the ethical issues presented in the two domains trans-
lates into a renewed conceptualisation of public trust and legit-
imisation. Our argument is sustained by empirical evidence
generated from recent studies on public attitudes to medical bio-
banks and forensic genetic databases.
PUBLIC TRUST AND LEGITIMISATION
In the recent political and academic debate, strengthening trust
in genetic databasing has been presented as imperative to the
legitimacy and maintenance of biobanks and forensic DNA data-
bases.5 16 Empirical studies on public attitudes to medical bio-
banks and forensic genetic databases have consistently shown
high levels of trust in scientiﬁc institutions, a positive vision of
genetic databasing and its expected results, strong motivation to
donate biological material based on feelings of altruism and
wanting to help others, and the public perception that the
forensic use of medical biobanks does not affect trust in health-
care services.14 20 22–24 However, the perception of societal ben-
eﬁts and the conﬁdence placed in genetic databasing, in both
forensic and medical ﬁelds, is challenged by scarcity of informa-
tion and concerns about lack of control and insufﬁcient or
unclear regulations concerning safeguarding individuals’ data
and supervising the access and uses of genetic data.
This ﬂow between public attitudes in the ﬁeld of medicine
and forensics translates into a renewed conceptualisation of
public trust and legitimisation, in four complementary ways.
First, it draws attention to the responsibility of scientiﬁc and
political institutions. Literature on bioethics has highlighted the
importance of incorporating biobanks and forensic databases
into creditable institutions that have the capacity to support
them, managed by trustworthy researchers, singling out univer-
sities and research centres or national forensic medicine institu-
tions.9 22 The need to regulate and implement a policy of truth
and transparency for the activities of biobanks and forensic
DNA databases has also been recognised, which safeguards indi-
vidual privacy and upholds the trust placed in them. Detailing
the interests of the many players involved in the respective gov-
ernance and clarifying the conditions for using, accessing and
disseminating data represent steps forward in this direction.
Second, it highlights the importance of providing accurate and
timely information to data subjects, in particular about the
purpose and objectives of the biobank and its governance struc-
tures, possible and inadmissible uses of the samples, variables to
be registered in the database, storage time and availability of
samples, type of samples stored, procedures associated with the
recovery of samples and data, terms under which samples and
data can be accessed, rights of individuals, and a list of the fore-
seeable risks and beneﬁts. Third, it asks for assurance that the
public will be involved and protected by consulting their opi-
nions about the functioning of biobanks and forensic DNA data-
bases. Finally, it calls for adjustment between the expectations
and responsibilities of all players involved to the reality of
medical research and also to the use of genetic databases to
support criminal investigation and prosecution activities.
Overall, fostering public trust and legitimisation are a matter of
addressing not only individual rights and needs, but also the rights
and needs of communities and social groups. We therefore argue
that it is necessary to move beyond the individualistic approach to
ethics in which the focus has been the debate on the restriction of
civil rights, since the aim of genetic databases is to act in the public
interest.7 15 17 In addition, actions directed towards a collective
rather than an individual perspective may exist, on the part of
both ‘non-criminals’ whose proﬁles may be stored in databases
and individuals convicted of crimes whose proﬁles (and, in some
jurisdictions, samples as well) are included in forensic DNA data-
bases.11 14 24 Actions of this nature may also emerge in healthcare,
particularly in studies involving disease registries and investigations
into public health emergencies in which the collective dimension
and public interest overshadow individual responsibilities and pro-
tection of the rights of individuals.2 4 9 17 18 20 25
The perception of genetic databases as civic projects and
arenas for negotiation between the interests of public and
private institutions and individual and collective rights and
duties calls for community ethics, as has been advocated in the
context of medical and research biobanks.8 9 25 We propose a
renewed ethical debate by arguing that such a solidarity-based
approach could be meaningfully extended to public participa-
tion in forensic DNA databases, as explored in the next section.
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THE PRINCIPLE OF SOLIDARITY
Solidarity has been discussed as an emerging concept in bioeth-
ics,25 26 advocating community ethics associated with practices
and commitments that are shared, in ﬁnancial, social and emo-
tional terms, with common assets, combining individual and
collective responsibilities and relying on the contributions of all
to ensure that all will beneﬁt. An approach based on solidarity
also includes introducing mechanisms for public participation
guided by the principles of respect, veracity and transparency,
prioritising research that is not designed for ﬁnancial gain,
developing harm mitigation strategies, and ensuring that citizens
may exercise their right to information. It involves not only
technical and scientiﬁc issues but also a discussion of the pur-
poses of digniﬁed and beneﬁcial data processing, guided by the
following main principles, which may cross the borders between
medical and forensic genetic databases: reinforcement of the
subject’s right to be informed and to give consent; transparency
with regard to the purposes, risks, beneﬁts and actors involved
in processing personal data; monitoring, supervision and
accountability by independent citizens and institutions; manage-
ment of conﬂicts of interest by balancing public and private
interests and individual and collective interests; consultation of
the public.17
Incorporation of the principle of solidarity in relation to
forensic DNA databases might be particularly relevant regarding
the forensic uses of medical biobanks and in relation to the
exchange of DNA data between countries for forensic purposes.
Although all Western criminal jurisdictions ban the speculative
automated exchange of information between forensic and
medical contexts, in exceptional circumstances (for instance, for
identiﬁcation of victims of mass disasters and catastrophes)
forensic use of medical biobanks is allowed.4 EU Law, through
Decisions 2008/615/JHA and 2008/616/JHA (EU Council,
2008), establishes a pan-European system for the transnational
exchange of forensic genetic data between EU countries, for the
purpose of combating cross-border crime, terrorism and illegal
immigration. More than 10 million individuals’ DNA proﬁles
will be exchanged between agencies in all EU countries on a
routine and automated basis, in a context marked by lack of
transparency and accountability.6
Inclusion of a solidarity-based framework may reinforce
public participation in both medical and forensic genetic data-
bases, and ensure greater transparency in terms of access to, and
use of, personal data and the independence of controllers. As
suggested by Prainsack and Buyx,25 the credibility of biobanks
and the trust placed in them are essential to achieving a three-
tier model of solidarity: on an interpersonal level, it is necessary
for people to be often willing to accept the costs (the risk of
losses and the inconvenience of participating) in order to help
others on the basis of the notion of similarity and the fact that
solidarity-based biobanks are not unduly exploited for ﬁnancial
gain; on a group level, the participants and the biobanks
become partners in projects that focus on their common inter-
ests and negotiate common forms of conduct in order to
achieve shared objectives, rather than merely acting as parties to
a contract; on a contractual level, the obligations arising out of
the regulation and governance of biobanks are respected.
CONCLUSION
Solidarity raises new questions that should be included in the
ethical debate, with regard to crime prevention, investigation
and prosecution as well as healthcare services and research.
They include the balance between individual and collective
beneﬁts and responsibilities, and reﬂections on the fair, efﬁcient
and effective allocation and use of existing genetic databases in
different national contexts in order to offset inequalities
between social groups and Member States. It is a matter of pro-
actively assessing the current and future beneﬁts and risks for
the public in a context in which biobanks and forensic DNA
databases are seen as social entities or assets that must make
their conduct explicit to the participants on the basis of commu-
nity values and the social, political and ethical consequences of
medical research or criminal investigation. Certain questions
need to be clariﬁed and analysed in greater detail: rights of own-
ership with regard to personal data and biobanks; the unequal
distribution of risks and beneﬁts among populations; conﬂicts
of interests involving the protection of individual rights; the
relationship between public and private biobanks and between
research, industrial and/or business interests and criminal inves-
tigation work; and the ways in which the public is represented
before independent controllers.
This discussion might be also framed to serve present or
future public assets indispensible to other community and public
beneﬁts, such as the ﬁght against crime or the promotion of
healthcare. The balance between individual and collective
rights, the state–citizen relationship, and notions of human
nature and social commitments to what is worth protecting, and
the reasons for this, involves complex values and normativities
that are culturally and historically bounded and need to be
empirically explored. This will allow public scrutiny of the work
of biobanks and forensic DNA databases and the responsible
dissemination of results to individuals, the scientiﬁc community,
and the justice and healthcare systems.
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